Skip to main content
. Author manuscript; available in PMC: 2015 Mar 14.
Published in final edited form as: Br J Nutr. 2014 Jun 25;112(5):735–743. doi: 10.1017/S000711451400138X

Table 2. Combined risk of coronary heart (CHD) events and deaths for an additional intake of 1 g/d of alpha-linolenic acid (ALA).

All Women Men

HR (95 % CI) P for effect modification by gender HR (95 % CI) HR (95 % CI)
ALA, CHD events

Model 1 0.94 (0.82,1.08) 0.95 1.07 (0.66,1.74) 0.95 (0.86,1.05)
Model 2 0.93 (0.84,1.04) 0.88 0.96 (0.67,1.39) 0.95 (0.86,1.05)
Model 3 0.88 (0.75,1.02) 0.42 1.02 (0.65,1.59) 0.85 (0.72,1.01)

ALA, CHD deaths

Model 1 0.95 (0.82,1.09) 0.62 1.04 (0.64,1.68) 0.93 (0.80,1.09)
Model 2 0.96 (0.83,1.11) 0.97 0.96 (0.64,1.45) 0.96 (0.82,1.13)
Model 3 0.88 (0.68,1.14) 0.07 1.23 (0.80,1.89) 0.77 (0.58,1.01)

Data are given as hazard ratios (HR) and 95% confidence intervals (CI) by using Cox proportional hazards regression. Model 1 included intake of ALA expressed in energy adjusted g/d. Age at baseline (y) and the calendar year in which the baseline questionnaire was returned were entered into the model through the strata statement. Model 2 included the variables of model 1 and the following known risk factors for CHD: smoking habits, body mass index, physical activity, educational level, history of hypertension. Model 3 included the variables of model 2 and the following dietary risk factors: alcohol intake, total energy intake (where alcohol is excluded), fibre intake, monounsaturated fatty acid, saturated fatty acid, trans fatty acids, long-chain n-3 fatty acids, and linoleic acid intake